Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-17T17:21:06.375Z Has data issue: false hasContentIssue false

Enhanced survival of ST-11 carbapenem-resistant Klebsiella pneumoniae in the intensive care unit

Published online by Cambridge University Press:  27 March 2020

Ying Liu
Affiliation:
Center for Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Center for Pathogen Research, West China Hospital, Sichuan University, Chengdu, China
Xiaoxia Zhang
Affiliation:
Center for Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Center for Pathogen Research, West China Hospital, Sichuan University, Chengdu, China
Lin Cai
Affiliation:
Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, China
Zhiyong Zong*
Affiliation:
Center for Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Center for Pathogen Research, West China Hospital, Sichuan University, Chengdu, China Department of Infection Control, West China Hospital, Sichuan University, Chengdu, China
*
Author for correspondence: Zhiyong Zong, E-mail: zongzhiy@scu.edu.cn
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

To the EditorKlebsiella pneumoniae, a gram-negative bacterium of the Enterobacteriaceae, is a well-known and major pathogen. Carbapenems are the mainstream agent of choice against K. pneumoniae–producing extended-spectrum β-lactamases (ESBLs). However, carbapenem-resistant K. pneumoniae (CRKP) has increased rapidly worldwide and has become an urgent threat to public health. CRKP belongs to various sequence types (STs), and ST-11 is the dominant type of CRKP in China.Reference Qi, Wei and Ji1 However, the factors contributing to the dominance of ST-11 remain largely unknown. Admission to the intensive care unit (ICU) and prolonged length of stay in the ICU are major risk factors for CRKP infection.Reference Liu, Li and Luo2Reference van Dorp, Wang and Shaw4 We hypothesized that ST-11 may have better survival in the ICU than other types of CRKP. We investigated the survival of ST-11 CRKP, a few other types of CRKP, and carbapenem-susceptible K. pneumoniae (CSKP) on a polyvinyl chloride (PVC) surface at the room temperature and humidity in a real ICU situation.

We selected 6 ST11 CRKP strains, 4 CRKP of other STs (ST1, ST15, ST37, and ST45) and 1 CSKP strain (ST1229) for study. Bacteria from frozen stocks were cultured on Luria-Bertani (LB) agar overnight at 37°C. A single colony of each strain was incubated in 5 mL LB broth for ~3–5 hours to midexponential growth phase; the mixture was then centrifuged, washed, resuspended in 1 mL PBS, and finally adjusted to 0.5 MacFarland turbidity-equivalent standard (108 CFU/mL). Aliquots (10 μL) of each strain were added to wells (3 wells per strain) of a sterile PVC 96-well plate (Corning, NY). The plates were dried in ambient air overnight in a clean biosafety cabinet. Afterward, the plates were put into a paper box, which was placed in a corner of the corridor in an ICU ward of our hospital. This location was away from patient-care areas, and ICU staff were notified of the location to avoid any potential contact. The temperature and relative humidity of the ICU were maintained at 25 ± 2°C and 54 ± 4%, respectively. To recovery bacterial cells, 200 μL PBS was added into each well and shaken at 85 ± 5 rpm for 60 minutes in a miniature orbital shaker (BETS-M1; Qilinbeier, Haimen, Jiangsu, China). The 100-μL bacterial suspension was streaked on LB agar, which was incubated at 37°C overnight, and the number of colonies was counted manually. The biofilm formation of these strains was facilitated by aerobic incubation at 37°C in a microtiter plate system, as described previously.Reference Jousset, Bonnin and Rosinski-Chupin5 All statistics were determined using GraphPad Prism version 8.0.2 software (GraphPad Software, San Diego, CA). The statistical techniques employed for analysis were descriptive statistics and unpaired t test with a Welch correction.Reference Jousset, Bonnin and Rosinski-Chupin5P values < .05 were considered statistically significant.

All samples survived for >3 days on the PVC surface in the ICU (Table 1). ST-11 strains exhibited longer survival than non–ST-11 strains (P = .024) (Fig. 1, panel A). No significant difference was observed in biofilm formation between ST-11 and non–ST-11 strains in this study (P = .235), suggesting that the prolonged survival of ST11 strains was not due to biofilm formation (Fig. 1, panel B). A previous study also found no relationship between biofilm formation of K. pneumoniae and the transmission in ICU.Reference Surgers, Boyd, Girard, Arlet and Decre6

Table 1. Strains and Their Survivals in the Intensive Care Unit

Note. ST, sequence type; OD, optical density; ICU, intensive care unit; RICU, respiratory ICU.

Fig. 1. Survival and biofilm formation of ST11 and non-ST11 K. pneumoniae. Panel A, duration of survival days of ST11 and non-ST11 K. pneumoniae. Panel B, biofilm formation of ST11 and non-ST11 K. pneumoniae.

Therefore, ST-11 CRKP shows an advantage in survival days compared to non–ST-11 CRKP, which may contribute to its wide spread in healthcare settings such as the ICU. To our knowledge, this is the first study to demonstrate that ST-11 K. pneumoniae strains can survive longer than several other types of CRKP in a real ICU environment. These findings support the essential role of environmental cleaning in preventing the in-hospital transmission of CRKP.

Financial support

This work was supported by grants from the National Natural Science Foundation of China (grant nos. 81861138055 and 81661130159), by the West China Hospital of Sichuan University (grant no. ZYYC08006), and by the Newton Advanced Fellowship, Royal Society, United Kingdom (grant no. NA150363).

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

Qi, Y, Wei, Z, Ji, S, et al.ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011;66:307312.10.1093/jac/dkq431CrossRefGoogle ScholarPubMed
Liu, P, Li, X, Luo, M, et al.Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist 2018;24:190198.10.1089/mdr.2017.0061CrossRefGoogle ScholarPubMed
Xu, L, Sun, X, Ma, X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 2017;16:18.10.1186/s12941-017-0191-3CrossRefGoogle ScholarPubMed
van Dorp, L, Wang, Q, Shaw, LP, et al.Rapid phenotypic evolution in multidrug-resistant Klebsiella pneumoniae hospital outbreak strains. Microb Genom 2019;5(4):e000263.Google ScholarPubMed
Jousset, AB, Bonnin, RA, Rosinski-Chupin, I, et al.A 4.5-year within-patient evolution of a colistin-resistant Klebsiella pneumoniae carbapenemase–producing K. pneumoniae sequence type 258. Clin Infect Dis 2018;67:13881394.10.1093/cid/ciy293CrossRefGoogle ScholarPubMed
Surgers, L, Boyd, A, Girard, PM, Arlet, G, Decre, D. Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae. Int J Med Microbiol 2019;309:1318.10.1016/j.ijmm.2018.10.008CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Strains and Their Survivals in the Intensive Care Unit

Figure 1

Fig. 1. Survival and biofilm formation of ST11 and non-ST11 K. pneumoniae. Panel A, duration of survival days of ST11 and non-ST11 K. pneumoniae. Panel B, biofilm formation of ST11 and non-ST11 K. pneumoniae.